 | Precigen, Inc. | |||
| NMS : PGEN || Location: United States | ||||
$1.38+0.05 (+3.76%) |
0.89 M | 1.32 - 1.39 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 16.901 M |
| March 15, 2024 | 16.910 M |
| Feb. 29, 2024 | 17.271 M |
| Feb. 15, 2024 | 17.537 M |
| Jan. 31, 2024 | 18.708 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.08 | -0.13 | -64.35% |
| 09/30/2023 | -0.08 | -0.08 | -0.50% |
| 06/30/2023 | -0.10 | -0.08 | 21.57% |
| 03/31/2023 | -0.09 | -0.10 | -7.41% |
| 12/31/2022 | -0.10 | -0.11 | -7.84% |
PGEN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 248.919M | Shares Float | 122.478M |
| Short Float | 16.901M | Market Cap | 343.51M |
| Institution ownership | 64.49% | Insider ownership | 11.722% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.39 | Forward EPS | -0.27 |